CN101199845A - 一种稳定的抗IgE人源化单抗制剂 - Google Patents
一种稳定的抗IgE人源化单抗制剂 Download PDFInfo
- Publication number
- CN101199845A CN101199845A CNA2006101472823A CN200610147282A CN101199845A CN 101199845 A CN101199845 A CN 101199845A CN A2006101472823 A CNA2006101472823 A CN A2006101472823A CN 200610147282 A CN200610147282 A CN 200610147282A CN 101199845 A CN101199845 A CN 101199845A
- Authority
- CN
- China
- Prior art keywords
- agent
- ige
- preparation
- described preparation
- monoclonal antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
保存条件 | No.1 | No.2 | No.3 | No.4 | No.5 | No.6 | No.7 |
4℃,避光,3年 | 104% | 92% | 97% | 95% | 96% | 94% | 99% |
30℃,避光,1年 | 96% | 90% | 96% | 95% | 92% | 101% | 96% |
重建制剂,2-8℃,3个月 | 107% | 90% | 95% | 95% | 91% | 96% | 95% |
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101472823A CN101199845B (zh) | 2006-12-14 | 2006-12-14 | 一种稳定的抗IgE人源化单抗制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101472823A CN101199845B (zh) | 2006-12-14 | 2006-12-14 | 一种稳定的抗IgE人源化单抗制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101199845A true CN101199845A (zh) | 2008-06-18 |
CN101199845B CN101199845B (zh) | 2012-05-23 |
Family
ID=39515329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006101472823A Active CN101199845B (zh) | 2006-12-14 | 2006-12-14 | 一种稳定的抗IgE人源化单抗制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101199845B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102327612A (zh) * | 2010-07-13 | 2012-01-25 | 上海张江生物技术有限公司 | 一种稳定的人源化单克隆抗体制剂 |
CN103282042A (zh) * | 2010-09-17 | 2013-09-04 | 巴克斯特国际公司 | 通过具有组氨酸的水性制剂在弱酸性至中性pH稳定的免疫球蛋白 |
CN105920600A (zh) * | 2016-04-19 | 2016-09-07 | 上海景泽生物技术有限公司 | 一种稳定的抗vegf抗体制剂及其用途 |
WO2021136274A1 (zh) * | 2019-12-30 | 2021-07-08 | 百奥泰生物制药股份有限公司 | 含抗Trop2抗体-药物偶联物的制剂及其制备方法和应用 |
CN113583134A (zh) * | 2020-04-30 | 2021-11-02 | 天辰生物医药(苏州)有限公司 | 分离的抗原结合蛋白及其用途 |
CN114632150A (zh) * | 2017-11-02 | 2022-06-17 | 正大天晴药业集团股份有限公司 | 一种抗pd-l1人源化单克隆抗体的药物组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL122910A (en) * | 1995-07-27 | 2002-05-23 | Genentech Inc | Stable isotonic protein formulation that has undergone lyophilization |
-
2006
- 2006-12-14 CN CN2006101472823A patent/CN101199845B/zh active Active
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102327612A (zh) * | 2010-07-13 | 2012-01-25 | 上海张江生物技术有限公司 | 一种稳定的人源化单克隆抗体制剂 |
CN103282042A (zh) * | 2010-09-17 | 2013-09-04 | 巴克斯特国际公司 | 通过具有组氨酸的水性制剂在弱酸性至中性pH稳定的免疫球蛋白 |
CN103282042B (zh) * | 2010-09-17 | 2014-12-10 | 巴克斯特国际公司 | 通过具有组氨酸的水性制剂在弱酸性至中性pH稳定的免疫球蛋白 |
CN105920600A (zh) * | 2016-04-19 | 2016-09-07 | 上海景泽生物技术有限公司 | 一种稳定的抗vegf抗体制剂及其用途 |
CN114632150A (zh) * | 2017-11-02 | 2022-06-17 | 正大天晴药业集团股份有限公司 | 一种抗pd-l1人源化单克隆抗体的药物组合物 |
CN114632150B (zh) * | 2017-11-02 | 2023-12-19 | 正大天晴药业集团股份有限公司 | 一种抗pd-l1人源化单克隆抗体的药物组合物 |
WO2021136274A1 (zh) * | 2019-12-30 | 2021-07-08 | 百奥泰生物制药股份有限公司 | 含抗Trop2抗体-药物偶联物的制剂及其制备方法和应用 |
CN113583134A (zh) * | 2020-04-30 | 2021-11-02 | 天辰生物医药(苏州)有限公司 | 分离的抗原结合蛋白及其用途 |
CN113583134B (zh) * | 2020-04-30 | 2024-06-04 | 天辰生物医药(苏州)有限公司 | 分离的抗原结合蛋白及其用途 |
Also Published As
Publication number | Publication date |
---|---|
CN101199845B (zh) | 2012-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230047111A1 (en) | Pharmaceutical formulations of tnf-alpha antibodies | |
US11498959B2 (en) | Anti-CGRP antibody formulation | |
CN101199845B (zh) | 一种稳定的抗IgE人源化单抗制剂 | |
EP2236154B1 (en) | Immunoglobulin formulation and method of preparation thereof | |
Brand et al. | Pharmacokinetics of empagliflozin, a sodium glucose cotransporter-2 (SGLT-2) inhibitor, coadministered with sitagliptin in healthy volunteers | |
EP2399604A1 (en) | Novel antibody formulation | |
CN101199483B (zh) | 一种稳定的抗her2人源化抗体制剂 | |
CN102327612A (zh) | 一种稳定的人源化单克隆抗体制剂 | |
CN111375057A (zh) | 一种包含抗Her2单克隆抗体的药物配制剂 | |
CN114306218B (zh) | 满足药学抑菌要求的经粘膜给药r-氯胺酮药物组合物 | |
US20230174640A1 (en) | Use of Anti-IL-6 Antibody, e.g., Clazakizumab for Treatment/Prevention of ARDS Associated with Coronavirus (COVID-19) Infection | |
CN112656939A (zh) | 一种针对血管内皮生长因子的人源化抗体的药物组合物 | |
CN102309754A (zh) | 一种稳定的重组人源化抗体的药物组合物 | |
US20240052026A1 (en) | Stable antibody formulation, preparation method therefor, and applications thereof | |
CN114306219B (zh) | 稳定的r-氯胺酮药物组合物 | |
WO2023173615A1 (zh) | 一种稳定的酯肽类药物水溶液 | |
US20200289650A1 (en) | Stable Glucocorticoid Formulation | |
US20220184173A1 (en) | Stable pharmaceutical formulations of peptide and protein drugs | |
WO2023165050A1 (zh) | 一种稳定的酯肽类药物组合物 | |
US20150150983A1 (en) | Intra-articular Formulations and Methods for Treatment of Osteoarthritis | |
EP3530279B1 (en) | Pharmaceutical composition for use in treating female sexual dysfunctions | |
EP3287139B1 (en) | Nerve growth factor composition and injection powder | |
TW202306992A (zh) | 第i型黏多醣症之治療用醫藥組成物 | |
WO2022264097A1 (en) | Pharmaceutical composition of anti-tumour necrosis factor (anti-tnf) agent for management of infectious diseases caused by coronaviruses | |
EP3287141A1 (en) | Nerve growth factor composition and powder injection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI ZHANGJIANG BIO-TECH CO., LTD. Free format text: FORMER OWNER: SHANGHAI GUOJIAN BIOTECHNOLOGY INSTITUTE Effective date: 20150518 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150518 Address after: 201203 Shanghai Guo Shou Jing Road, Zhangjiang High Tech Park of Pudong New Area No. 351 Building No. 1 room 440 Patentee after: Shanghai Zhangjiang Bio-Tech Co., Ltd. Address before: 201203 Shanghai city Pudong New Area Jing Road No. 351 Building No. 1 room 431 Patentee before: Shanghai Guojian Biological Technology Institute |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180730 Address after: 225316 G79, west side of Tai Lu Road, Lu Jia Road, Chinese medicine, Taizhou, Jiangsu. Patentee after: Taizhou Mai BARTEC Pharmaceutical Co. Ltd. Address before: 201203 room 440, 1 building, No. 351, Guo Shou Jing Road, Zhangjiang hi tech park, Pudong New Area, Shanghai. Patentee before: Shanghai Zhangjiang Bio-Tech Co., Ltd. |